Theseus Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	0.62	2.67	0.83	0.84	1.79
Accounts Receivable	1.73	0.86	6.11	2.05	2.58
Other Receivables	-	0	-	-	-
Property, Plant & Equipment	0.35	0.3	0.09	0.15	0
Other Intangible Assets	0.06	0.06	0.06	0.06	0.06
Restricted Cash	7.26	6.27	5.49	7	13.12
Other Current Assets	4.15	2.45	0.07	0.04	0.1
Long-Term Deferred Tax Assets	0.02	0	0	-	0
Other Long-Term Assets	1.69	3.96	0.03	0.05	0.03
Total Assets	15.9	16.58	13.13	10.23	17.69
Accounts Payable	8.43	6.91	10.29	7.86	14.9
Accrued Expenses	0.25	0.08	0.02	0.07	0.09
Current Portion of Leases	0.12	0.09	0.07	0.07	-
Other Current Liabilities	0.26	-	0.8	2.04	2.05
Long-Term Leases	0.08	0.2	-	0.07	-
Long-Term Deferred Tax Liabilities	-	-	-	0	-
Total Liabilities	9.2	7.3	11.18	10.1	17.04
Common Stock	0	0	0	0	0
Additional Paid-In Capital	15.72	14.03	2.02	-	-
Retained Earnings	-8.99	-4.67	-0.08	0.13	0.64
Comprehensive Income & Other	-0.03	-0.08	0	-0	0
Shareholders' Equity	6.7	9.29	1.95	0.13	0.64
Total Liabilities & Equity	15.9	16.58	13.13	10.23	17.69
Total Debt	0.2	0.29	0.07	0.14	-
Net Cash (Debt)	0.43	2.38	0.76	0.7	1.79
Net Cash Growth	-82.09%	212.99%	8.40%	-60.79%	-
Net Cash Per Share	0.03	0.17	0.07	0.08	-
Filing Date Shares Outstanding	15.63	15.63	11.48	10	-
Total Common Shares Outstanding	15.63	15.63	11.48	10	-
Working Capital	4.66	5.16	1.32	-0.1	0.54
Book Value Per Share	0.43	0.59	0.17	0.01	-
Tangible Book Value	6.64	9.22	1.88	0.06	0.58
Tangible Book Value Per Share	0.42	0.59	0.16	0.01	-

Updated Jan 24, 2025. Source: S&P Global Market Intelligence. Capital Markets template. Financial Sources.

SEC Filings: 10-K · 10-Q